ScoreWhy is PharmaBlock Sciences (Nanjing), Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.32% and Operating profit at -4.94% over the last 5 years
2
Flat results in Mar 26
- OPERATING PROFIT(Q) Lowest at CNY 49.29 MM
- OPERATING PROFIT MARGIN(Q) Lowest at 9.7 %
3
With ROE of 3.52%, it has a fair valuation with a 1.09 Price to Book Value
- Over the past year, while the stock has generated a return of -1.92%, its profits have fallen by -6%
- At the current price, the company has a high dividend yield of 0
4
Below par performance in long term as well as near term
- Along with generating -1.92% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to PharmaBlock Sciences (Nanjing), Inc. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is PharmaBlock Sciences (Nanjing), Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
PharmaBlock Sciences (Nanjing), Inc.
33.93%
0.67
42.50%
China Shanghai Composite
3.0%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.32%
EBIT Growth (5y)
-4.94%
EBIT to Interest (avg)
8.41
Debt to EBITDA (avg)
0.29
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.36
Tax Ratio
10.37%
Dividend Payout Ratio
31.82%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.44%
ROE (avg)
11.32%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
1.42
EV to EBIT
36.45
EV to EBITDA
23.15
EV to Capital Employed
1.51
EV to Sales
3.42
PEG Ratio
NA
Dividend Yield
0.60%
ROCE (Latest)
4.14%
ROE (Latest)
3.52%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at -23.13 %
INVENTORY TURNOVER RATIO(HY)
Highest at 2.06 times
DIVIDEND PAYOUT RATIO(Y)
Highest at 46.08%
RAW MATERIAL COST(Y)
Fallen by -4.68% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 6.12 times
DIVIDEND PER SHARE(HY)
Highest at CNY 6.12
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for PharmaBlock Sciences (Nanjing), Inc.
Debt-Equity Ratio
Lowest at -23.13 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2.06 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 6.12 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Dividend per share
Highest at CNY 6.12
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (CNY)
Dividend Payout Ratio
Highest at 46.08%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by -4.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
